Antibody composition for detecting treatment effect of multiple myeloma as well as kit and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BEIJING JISHUITAN HOSPITAL
- Publication Date
- 2021-04-23
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine, and relates to an antibody composition for detecting the therapeutic effect of multiple myeloma, a kit and application thereof. Background technique
[0002] Multiple myeloma is a malignant hematological tumor, and patients cannot be cured, requiring continuous chemotherapy for at least 2 years or even long-term continuous treatment. Patients receiving chemotherapy need to undergo bone marrow aspiration every two months in order to comprehensively evaluate the treatment effect in combination with other indicators. Currently, the internationally recognized indicators for evaluating curative effect include blood immunoglobulin quantification, urine light chain quantification, the proportion of plasma cells in bone marrow aspiration, and imaging examinations. Among them, bone marrow puncture is a kind of invasive examination, which needs to be performed under anesthesia. The patient has certain...